Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Chemours (CC)

Chemours swings to $386 million 2025 net loss; Q4 adjusted EBITDA falls to $128 million

Negative Impact 4 of 5 earnings Written later

Chemours reported a fourth-quarter 2025 net loss of $47 million, or $0.31 per diluted share, versus a $11 million loss a year earlier, on net sales of $1.3 billion, down 2%. For full year 2025, the company posted a $386 million net loss ($2.57 per diluted share) after net income of $69 million in 2024, driven by litigation-related charges. The company also guided to 2026 adjusted EBITDA of $800 million to $900 million, which shareholders can use as a benchmark for future results.

Key points

  • Q4 2025 net loss attributable to Chemours was $47 million, or $0.31 per diluted share, vs. a $11 million loss, or $0.08 per share, a year earlier
  • Q4 2025 adjusted EBITDA was $128 million, down from $168 million; full year adjusted EBITDA was $742 million vs. $768 million
  • Full year 2026 outlook calls for net sales growth of 3% to 5% and adjusted EBITDA of $800 million to $900 million
  • Sale of the former Kuan Yin TiO2 site was announced January 15, 2026, for approximately $300 million in net proceeds

The filing

CompanyChemours (CC)
Form8-K, current report
Filed with the SECFeb 19, 2026, 4:40 PM ET
Accession number0001193125-26-059564

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 19, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.